Home/Filings/4/0001209191-14-049261
4//SEC Filing

Sucampo Pharmaceuticals, Inc. 4

Accession 0001209191-14-049261

CIK 0001365216operating

Filed

Jul 27, 8:00 PM ET

Accepted

Jul 28, 8:45 PM ET

Size

9.4 KB

Accession

0001209191-14-049261

Insider Transaction Report

Form 4
Period: 2014-07-24
Kuno Sachiko
Director10% Owner
Transactions
  • Sale

    Class A Common Stock

    2014-07-25$6.25/sh555$3,46922,783,802 total(indirect: By LLC)
  • Sale

    Class A Common Stock

    2014-07-24$6.26/sh15,600$97,62222,784,357 total(indirect: By LLC)
Holdings
  • Class A Common Stock

    (indirect: By Spouse)
    353,530
  • Class A Common Stock

    60,357
Footnotes (5)
  • [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by S&R Technology Holdings, LLC on September 11, 2013.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.25 to $6.31, inclusive. The reporting person undertakes to provide to Sucampo Pharmaceuticals, Inc., any security holder of Sucampo Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]S&R Technology Holdings, LLC is wholly owned by Dr. Kuno and her husband. Dr. Kuno disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.25 to $6.26, inclusive. The reporting person undertakes to provide to Sucampo Pharmaceuticals, Inc., any security holder of Sucampo Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F5]Dr. Kuno disclaims beneficial ownership of the reported securities.

Issuer

Sucampo Pharmaceuticals, Inc.

CIK 0001365216

Entity typeoperating

Related Parties

1
  • filerCIK 0001365216

Filing Metadata

Form type
4
Filed
Jul 27, 8:00 PM ET
Accepted
Jul 28, 8:45 PM ET
Size
9.4 KB